from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3838c/pheA

LFCtreatmentdescriptionclass of inhibitor

-1.539

Amikacinug/mL Amikacintranslation

0.082

Cap5-10ug/mL Capreomycintranslation

-0.223

Rox10-50 ug/mL Roxithromycintranslation

0.261

SM2-5 ug/mL Streptomycintranslation

-1.172

Tet5-10 ug/mL Tetracyclinetranslation

-1.299

Rif0.2-5ug/mL Rifampicintranscription

-0.081

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.695

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.298

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.371

CPZ10-50 ug/mL Chlorpromazinerespiration

0.176

Clofazimine10-13 ug/mL Clofaziminerespiration

0.078

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.092

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.512

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.032

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.057

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.128

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.305

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.178

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.427

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.653

KCN5-20 ug/mL Potassium cyaniderespiration

-0.007

NaN30.2-2 mM Sodium aziderespiration

0.847

Nigericin50 uM Nigericinrespiration

-1.415

TRC10-150 ug/mL Triclosanrespiration

-0.208

TRZ10-25 ug/mL Thioridazinerespiration

0.510

Valinomycin0.5-10 uM Valinomycinrespiration

0.192

ZnSO42 mM ZnSO4respiration

0.295

menadione6-10 ug/mL Menadionerespiration

1.034

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.509

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.810

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.099

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.777

NRP_1Non-replicating persistence stage 1dosRassociated

0.568

Amp0.2mg/mL AmpicillincellWall

0.244

Cephalexin20-100 ug/mL CephalexincellWall

1.214

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.315

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.375

EMB10-20 ug/mL EthambutolcellWall

-1.310

Eta12-40 ug/mL EthionamidecellWall

-1.068

INH0.2-0.4 ug/mL IsoniazidcellWall

-1.110

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.344

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.250

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.804

BZA0.12 mg/mL BenzamidearomaticAmides

-0.193

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.324

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.388

H2O24 mM hydrogen peroxideDNAdamaging

-0.254

Levo10 ug/mL LevofloxacinDNAdamaging

0.425

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.323

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.954

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.566

UVUV-irradiationDNAdamaging

0.298

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.425

Antimycin12.5-50 ug/mL Antimycin A?

0.051

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.087

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.180

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.021

PA8240.2-2 ug/mL PA-824?

0.669

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.079

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.225

Verapamil50 uM Verapamil?

0.110

mercaptoethanol2 mM 2-Mercaptoethanol?

0.247

methoxatin10-20 ug/mL Methoxatin?